• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Pharmacovigilance Analytics

Your best resource for PV analytics news, content and innovation!

  • Home
  • Pharmacovigilance Analytics
    • Sources of data
    • Methods and tools
  • Signal Detection and Management in Pharmacovigilance
  • News
  • Opinion
  • About
  • Glossary

About

Welcome to PharmacovigilanceAnalytics.com!

This site will provide you with the latest information on pharmacovigilance analytics (PV analytics), with emphasis on new technological advances related to big data analytics, artificial intelligence, cognitive computing, data mining, text and information mining, and visualization tools, among others, and how they integrate with drug safety and pharmacovigilance.

You will also find the latest news to keep you up-to-date in the field. A manually picked selection of content curated by ourselves, will also give you the most relevant information found in scientific journals and publications.

I’m allowing you to get in my own pharmacovigilance analytics workshop, where I apply all sorts of techniques to drug safety and pharmacovigilance data, with the aim of extracting the diamond, data normally hide, even though I will not work on data mining exclusively.

Our passion is to help providing knowledge discovery on the factors governing the association between the exposure to a medicinal product and its effects on the population

My name is Jose Rossello and I am passionate about learning, teaching, and sharing what I learn. My medical specialty is Preventive Medicine and Public Health. I also hold a PhD in Public Health, and a Masters in Health Care Management.

Since very early in my career, I became interested in quantitative methods, like biostatistics and epidemiologic analysis, and their application to knowledge discovery. To me, analyzing data makes me feel exactly the same as if I was working at the bench trying to discover a new link, association, something new that could eventually help to improve the health of individuals and populations.

Epidemiologic surveillance, prevention and control of diseases and adverse events, whether or not associated to the use of medicines, are aspects of my work I am comfortable with. I came to the ‘industry’ through the door of drug safety and pharmacovigilance. I have worked as a PV scientist, PV physician and, why not, PV physician scientist!

That’s why my ideal situation is working on the field of data analysis applied to pharmacovigilance and drug safety, in a broad sense.

If you want to know more about myself, please go ahead and visit my LinkedIn profile at https://www.linkedin.com/in/jrossello/

Would you like to send me an email? Please use this email address: editor@pharmacovigilanceanalytics.com

Related Terms:
  • Term: Big Data
  • Term: Data Mining
  • Term: Drug Safety

Primary Sidebar

Subscribe in a reader

Search Website

Uses of Generative AI in Pharmacovigilance

Featured News / Posts

Signal Analytics Technology in Pharmacovigilance

Signal Analytics Technology in Pharmacovigilance: Enhancing Drug Safety Monitoring

Pharmacovigilance plays a crucial role in ensuring public safety by monitoring, … [Read More...] about Signal Analytics Technology in Pharmacovigilance: Enhancing Drug Safety Monitoring

8 Common FDA Applications for Drugs & Biologics

The U.S. Food and Drug Administration (FDA) has several types of applications … [Read More...] about 8 Common FDA Applications for Drugs & Biologics

Key IND Enabling Studies: Navigating Preclinical Development Regulations

Investigational New Drug (IND) applications represent a critical stage in the … [Read More...] about Key IND Enabling Studies: Navigating Preclinical Development Regulations

Pharmacokinetics and Pharmacodynamics (PKPD): Fundamentals in Drug Development and Therapeutic Effectiveness

Pharmacokinetics and pharmacodynamics are two fundamental pillars in the field … [Read More...] about Pharmacokinetics and Pharmacodynamics (PKPD): Fundamentals in Drug Development and Therapeutic Effectiveness

Current Regulations Regarding Reference Safety Information (RSI): Key Aspects and Updates

Regulatory authorities in the pharmaceutical industry have established standards … [Read More...] about Current Regulations Regarding Reference Safety Information (RSI): Key Aspects and Updates

Methods of Statistical Signal Detection in Patient Safety and Pharmacovigilance: Key Techniques and Approaches

In the realm of patient safety and pharmacovigilance, statistical signal … [Read More...] about Methods of Statistical Signal Detection in Patient Safety and Pharmacovigilance: Key Techniques and Approaches

Pharmacovigilance Signal Detection Software: Enhancing Drug Safety and Monitoring

Pharmacovigilance signal detection software plays a crucial role in … [Read More...] about Pharmacovigilance Signal Detection Software: Enhancing Drug Safety and Monitoring

What is a PBRER? Understanding Periodic Benefit-Risk Evaluation Reports

A Periodic Benefit-Risk Evaluation Report (PBRER) serves as a structured … [Read More...] about What is a PBRER? Understanding Periodic Benefit-Risk Evaluation Reports

Drug Safety vs Pharmacovigilance: Exploring Conceptual Differences

Drug safety and pharmacovigilance are crucial aspects of public … [Read More...] about Drug Safety vs Pharmacovigilance: Exploring Conceptual Differences

Which Sections of a DSUR Must Present Safety and Pharmacovigilance Quantitative Data: Key Components Explained

he Development Safety Update Report (DSUR) is a crucial document that serves as … [Read More...] about Which Sections of a DSUR Must Present Safety and Pharmacovigilance Quantitative Data: Key Components Explained

  • What is a DSUR (Development Safety Update Report)? An Essential Guide for Clinical Research
  • What is a BLA (Biologics License Application)? Essential Guide for Professionals
  • What is a PADER? – Periodic Adverse Drug Experience Report Explained

RSS ICH News

  • An error has occurred, which probably means the feed is down. Try again later.

RSS From Nature journal

  • Gene Therapy with Enterovirus 3 C Protease: A Promising Strategy for Various Solid Tumors
  • Exploratory analysis of long-term suppressive therapy with dalbavancin in ventricular assist device infections caused by Staphylococcus aureus
  • Designing and characterizing first Iranian study evaluating serum levels of lithium in patients for population pharmacokinetics (FIRELOLIPOP): baseline and first report
  • Application of new approach methodologies for nonclinical safety assessment of drug candidates
  • FAERS based disproportionality analysis and network pharmacology investigation of taxanes associated drug induced liver injury

Copyright © 2025 · News Pro on Genesis Framework · WordPress · Log in